BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 14630947)

  • 21. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B.
    Mimori K; Druck T; Inoue H; Alder H; Berk L; Mori M; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7456-61. PubMed ID: 10377436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
    Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
    BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of FHIT and WWOX fragile genes in cancer.
    Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
    Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma.
    Kameoka Y; Tagawa H; Tsuzuki S; Karnan S; Ota A; Suguro M; Suzuki R; Yamaguchi M; Morishima Y; Nakamura S; Seto M
    Oncogene; 2004 Dec; 23(56):9148-54. PubMed ID: 15480422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
    Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
    Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic instability of the tumor suppressor gene FHIT in normal human cells.
    Palumbo E; Tosoni E; Matricardi L; Russo A
    Genes Chromosomes Cancer; 2013 Sep; 52(9):832-44. PubMed ID: 23780737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.
    Hosseini SA; Horton S; Saldivar JC; Miuma S; Stampfer MR; Heerema NA; Huebner K
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1017-29. PubMed ID: 23929738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common fragile sites, extremely large genes, neural development and cancer.
    Smith DI; Zhu Y; McAvoy S; Kuhn R
    Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FRA3B and other common fragile sites: the weakest links.
    Huebner K; Croce CM
    Nat Rev Cancer; 2001 Dec; 1(3):214-21. PubMed ID: 11902576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common fragile genes and digestive tract cancers.
    Kuroki T; Tajima Y; Furui J; Kanematsu T
    Surg Today; 2006; 36(1):1-5. PubMed ID: 16378185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that instability within the FRA3B region extends four megabases.
    Becker NA; Thorland EC; Denison SR; Phillips LA; Smith DI
    Oncogene; 2002 Dec; 21(57):8713-22. PubMed ID: 12483524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Fragile Histidine Triad gene and breast cancer.
    Yang Q; Yoshimura G; Sakurai T; Kakudo K
    Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
    Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
    Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact.
    Wang L; Darling J; Zhang JS; Qian CP; Hartmann L; Conover C; Jenkins R; Smith DI
    Oncogene; 1998 Feb; 16(5):635-42. PubMed ID: 9482109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular parameters of genome instability: roles of fragile genes at common fragile sites.
    Pichiorri F; Ishii H; Okumura H; Trapasso F; Wang Y; Huebner K
    J Cell Biochem; 2008 Aug; 104(5):1525-33. PubMed ID: 18393361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
    Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
    Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common fragile sites and cancer (review).
    Smith DI; Huang H; Wang L
    Int J Oncol; 1998 Jan; 12(1):187-96. PubMed ID: 9454904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.
    Turner BC; Ottey M; Zimonjic DB; Potoczek M; Hauck WW; Pequignot E; Keck-Waggoner CL; Sevignani C; Aldaz CM; McCue PA; Palazzo J; Huebner K; Popescu NC
    Cancer Res; 2002 Jul; 62(14):4054-60. PubMed ID: 12124341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.
    Saldivar JC; Park D
    Genes Chromosomes Cancer; 2019 May; 58(5):317-323. PubMed ID: 30242938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.